Form 8-K - Current report:
SEC Accession No. 0001628280-25-001239
Filing Date
2025-01-13
Accepted
2025-01-13 07:50:34
Documents
49
Period of Report
2025-01-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xfor-20250113.htm   iXBRL 8-K 36007
2 EX-99.1 a991pressreleasedatedjanua.htm EX-99.1 18181
3 EX-99.2 a992x4investordeckupdate.htm EX-99.2 44532
7 a992x4investordeckupdate001.jpg GRAPHIC 64585
8 a992x4investordeckupdate002.jpg GRAPHIC 340390
9 a992x4investordeckupdate003.jpg GRAPHIC 136335
10 a992x4investordeckupdate004.jpg GRAPHIC 141378
11 a992x4investordeckupdate005.jpg GRAPHIC 127707
12 a992x4investordeckupdate006.jpg GRAPHIC 88830
13 a992x4investordeckupdate007.jpg GRAPHIC 121774
14 a992x4investordeckupdate008.jpg GRAPHIC 78557
15 a992x4investordeckupdate009.jpg GRAPHIC 126169
16 a992x4investordeckupdate010.jpg GRAPHIC 98666
17 a992x4investordeckupdate011.jpg GRAPHIC 118066
18 a992x4investordeckupdate012.jpg GRAPHIC 133038
19 a992x4investordeckupdate013.jpg GRAPHIC 121746
20 a992x4investordeckupdate014.jpg GRAPHIC 136608
21 a992x4investordeckupdate015.jpg GRAPHIC 99576
22 a992x4investordeckupdate016.jpg GRAPHIC 113824
23 a992x4investordeckupdate017.jpg GRAPHIC 129639
24 a992x4investordeckupdate018.jpg GRAPHIC 97713
25 a992x4investordeckupdate019.jpg GRAPHIC 127554
26 a992x4investordeckupdate020.jpg GRAPHIC 107795
27 a992x4investordeckupdate021.jpg GRAPHIC 95102
28 a992x4investordeckupdate022.jpg GRAPHIC 106874
29 a992x4investordeckupdate023.jpg GRAPHIC 130318
30 a992x4investordeckupdate024.jpg GRAPHIC 140170
31 a992x4investordeckupdate025.jpg GRAPHIC 107376
32 a992x4investordeckupdate026.jpg GRAPHIC 118410
33 a992x4investordeckupdate027.jpg GRAPHIC 134000
34 a992x4investordeckupdate028.jpg GRAPHIC 116074
35 a992x4investordeckupdate029.jpg GRAPHIC 95395
36 a992x4investordeckupdate030.jpg GRAPHIC 96647
37 a992x4investordeckupdate031.jpg GRAPHIC 99253
38 a992x4investordeckupdate032.jpg GRAPHIC 91264
39 image.jpg GRAPHIC 13901
40 x4logo.jpg GRAPHIC 4345
  Complete submission text file 0001628280-25-001239.txt   5575434

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20250113.xsd EX-101.SCH 1785
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20250113_lab.xml EX-101.LAB 23449
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20250113_pre.xml EX-101.PRE 13583
51 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20250113_htm.xml XML 2824
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 25524842
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)